One likely reason among others is linked to the relevance of SOD1 pathogenic mutations to the broader ALS populations, with SOD1 mutations representing 5% of all familial cases while more than 90% of ALS cases are considered sporadic. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.